One of the known markers for preterm birth is the ultrasonographically identified XL184 solubility dmso short cervix.[2, 9] As part of the randomized trials evaluating different interventions to treat the short cervix,[10] we collected amniotic fluid samples and aliquots were frozen for subsequent analysis. These samples were analyzed for inflammatory mediators through the Bio-Plex™ Array (Bio-Rad, Hercules, CA, USA). Regression analysis from this data identified monocyte chemotactic protein-1 (MCP-1) as the mediator most predictive of preterm delivery (among patients who received no intervention

in the randomized trials).[11] The sensitivity and specificity for predicting delivery <32 weeks were 91 and 86%, respectively, with a positive predictive value of 88% and negative predictive value of 90%. Although this was an example

of what looks to be a useful marker, most similar single markers failed to be reproducible in low-risk populations and in diverse clinical settings. This again highlights the heterogeneity of etiological factors responsible for preterm labor and the multifactorial cascades ending in uterine contraction and preterm labor. Using multiple Buparlisib purchase biomarkers from different and distinct biologic pathways may better predict the risk of preterm labor. In order to overcome the shortcomings of evaluating individual cytokines, we created a novel amniotic fluid inflammatory score based on a comprehensive evaluation of multiple cytokines and inflammatory mediators in asymptomatic women with short midtrimester cervix.[12] Amniotic fluid from singleton gestations (n = 44) with a cervical length of ≤25 mm between 16 and 24 weeks was assayed for 25 inflammatory mediators. Patient data were stratified according to gestational age at delivery (<34 versus ≥34 weeks) to determine whether there was a difference in the mediator Branched chain aminotransferase levels between these two groups. Mediators that reached statistical significance were

included in the amniotic fluid inflammatory score. Patients were assigned 1 point for each significant mediator if their level was in the upper quartile. The amniotic fluid inflammatory score was determined, and its relationship to other clinical characteristics was examined. The receiver-operator characteristic (ROC) curve yielded a score ≥8 as predictive of delivery prior to 34 weeks with a sensitivity of 87.0%, specificity of 100%, positive predictive value of 100%, and negative predictive value of 87.5%. In addition, when this scoring system was applied to a different cohort of patients[13] who were undergoing routine genetic amniocentesis, all of those patients were classified as having a low inflammatory score. None of those patient delivered prior to 35 weeks.